Montag & Caldwell’s Eli Lilly LLY Stock Holding History

Montag & Caldwell’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$13.7M	Buy	17,546 +4,731	+37%	+$3.68M	2.99%	17
2025 Q1	$10.6M	Buy	12,815 +11,135	+663%	+$9.27M	2.46%	20
2024 Q4	$1.3M	Buy	1,680 +934	+125%	+$773K	0.28%	40
2024 Q3	$661K	Hold	746	–	–	0.13%	61
2024 Q2	$675K	Hold	746	–	–	0.14%	62
2024 Q1	$580K	Hold	746	–	–	0.1%	62
2023 Q4	$435K	Hold	746	–	–	0.08%	63
2023 Q3	$401K	Hold	746	–	–	0.05%	71
2023 Q2	$350K	Hold	746	–	–	0.04%	78
2023 Q1	$256K	Hold	746	–	–	0.03%	80
2022 Q4	$273K	Hold	746	–	–	0.04%	78
2022 Q3	$241K	Hold	746	–	–	0.04%	84
2022 Q2	$242K	Buy	+746	New	+$224K	0.04%	88
2020 Q3	–	Sell	-1,420	Closed	-$233K	–	74
2020 Q2	$233K	Sell	1,420 -480	-25%	-$73.7K	0.02%	68
2020 Q1	$264K	Buy	+1,900	New	+$261K	0.02%	62

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Montag & Caldwell's LLY Position: Q2 2025 in Review

Montag & Caldwell increased its Eli Lilly (LLY) stake by 37% in Q2 2025, buying an estimated $3.68M and bringing the position to 17,546 shares worth $13.7M. The position accounts for 2.99% of the portfolio, ranked #17.

Montag & Caldwell first reported a position in LLY in Q1 2020 and has held it in 15 quarters since. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

Montag & Caldwell held 17,546 shares of Eli Lilly worth $13.7M as of Q2 2025.
Montag & Caldwell bought 4,731 Eli Lilly shares in Q2 2025, an estimated $3.68M.
Eli Lilly made up 2.99% of Montag & Caldwell's portfolio in Q2 2025, its #17 holding.
Montag & Caldwell first reported a position in Eli Lilly in Q1 2020 and has held it in 15 quarters since.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Montag & Caldwell's 13F filing for Q2 2025, filed 15 Aug 2025.